Salem Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$235K |
| 2 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$190K |
| 3 |
Dover
DOV
|
+$47.2K |
| 4 |
Kimberly-Clark
KMB
|
+$30.5K |
| 5 |
PCL
PLUM CREEK TIMBER CO (REIT)
PCL
|
+$21.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Herc Holdings
HRI
|
+$4.87M |
| 2 |
B
Barrick Mining
B
|
+$527K |
| 3 |
SLB Ltd
SLB
|
+$397K |
| 4 |
APC
Anadarko Petroleum
APC
|
+$387K |
| 5 |
Occidental Petroleum
OXY
|
+$385K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.25% |
| 2 | Energy | 17.54% |
| 3 | Technology | 15.04% |
| 4 | Industrials | 12.39% |
| 5 | Consumer Staples | 8.31% |
Similar funds
Salem Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Salem Capital Management held 75 positions worth $226M, down 1.2% from $228M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Salem Capital Management withdrew a net $13.2M in Q2 2014, closing 3 positions and reducing 43 holdings. Its most notable exit was Herc Holdings, an estimated $4.87M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Energy and Technology.
Against the trend, Salem Capital Management opened a new position in Royal Dutch Shell PLC ADS Class A worth $200K.
- Salem Capital Management's largest Q2 2014 buy was Royal Dutch Shell PLC ADS Class A: 2,433 shares worth $200K.
- Salem Capital Management added most to Pfizer in Q2 2014, an estimated $235K increase.
- Salem Capital Management's biggest Q2 2014 reduction was SLB Ltd, cutting an estimated $397K.
- Salem Capital Management fully exited Herc Holdings in Q2 2014, selling an estimated $4.87M.
- Salem Capital Management's ten largest holdings make up 34% of its $226M portfolio in Q2 2014.
- Salem Capital Management opened 1 new position and closed 3 in Q2 2014.
- Salem Capital Management's portfolio value fell 1.2% quarter-over-quarter to $226M.
Based on Salem Capital Management's 13F filing for Q2 2014, filed 17 Jul 2014.